Welcome to our investor pages
Medical technology company Optomed is leading producer of handheld fundus cameras globally.
Key figures
Net sales 15.1 EUR, million
Gross margin 68,2 %
EBITDA -1.5 EUR, million
Equity ratio 70,0 %
Share Price
Nasdaq Helsinki Stock Exchange
Optomed’s Interim Report January – September 2024
Read moreLatest releases
Investor events
Nov 7
- Nov 7, 2024
Interim Report for 1 January – 30 September 2024
Aug 8
- Aug 8, 2024
Half-Year Financial Report for 1 January – 30 June 2024
May 7
- May 7, 2024
Interim Report for 1 January – 31 March 2024
Feb 15
- Feb 15, 2024
Financial Statement Bulletin for 1 January – 31 December 2023
Nov 3
- Nov 3, 2023
Interim Report for 1 January – 30 September 2023
Aug 4
- Aug 4, 2023
Half-Year Financial Report for 1 January – 30 June 2023
Optomed as an investment
Optomed is a research and development as well as sales driven medical technology company in expansion phase.
Optomed is one of the leading players in the growing and transforming handheld fundus camera market.
Read more